BioCentury
ARTICLE | Company News

Anika, Galderma deal

July 10, 2006 7:00 AM UTC

ANIK granted Galderma exclusive worldwide rights to develop and commercialize hyaluronic acid cosmetic tissue augmentation (CTA) therapy for wrinkles, scars and lip augmentation. ANIK will receive $1 ...